Pricing and Reimbursement Issues for Pharmaceutical Products in Europe

Pricing and Reimbursement Issues for Pharmaceutical Products in Europe

 

RELEASE DATE
23-Nov-2005
REGION
Europe
Research Code: B705-01-00-00-00
SKU: HC01148-EU-MR_05221
AvailableYesPDF Download
$6,950.00
In stock
SKU
HC01148-EU-MR_05221
$6,950.00
DownloadLink
ENQUIRE NOW

Description

Pricing and reimbursement issues for pharmaceutical products in europe

Table of Contents

Executive Summary

  • Summary of the Pricing and Reimbursement Issues for Pharmaceutical Products in Europe

Overview

  • Scope
  • Key Abbreviations
  • Introduction
  • The Pharmaceutical Expenditure in EU
  • Pricing and Reimbursement
  • Issues with Pharmaceutical Pricing and Reimbursement in EU

Austria

  • Pharmaceutical in Austria
  • Austrian Pharmaceutical and Healthcare Industry SWOT Analysis
  • Pharmaceutical Pricing and Reimbursement
  • Industry Issues

Belgium

  • Pharmaceutical in Belgium
  • Belgian Pharmaceutical and Healthcare Industry SWOT Analysis
  • Pharmaceutical Pricing and Reimbursement
  • Industry Issues

Czech Republic

  • Pharmaceutical in Czech Republic
  • Czech Republic Pharmaceutical and Healthcare Industry SWOT Analysis
  • Pharmaceutical Pricing and Reimbursement
  • Industry Issues

Denmark

  • Pharmaceutical in Denmark
  • Denmark Pharmaceutical and Healthcare Industry SWOT Analysis
  • Pharmaceutical Pricing and Reimbursement
  • Industry Issues

Estonia

  • Pharmaceutical in Estonia
  • Estonia Pharmaceutical and Healthcare Industry SWOT Analysis
  • Pharmaceutical Pricing and Reimbursement
  • Industry Issues

Finland

  • Pharmaceutical in Finland
  • Finnish Pharmaceutical and Healthcare Industry SWOT Analysis
  • Pharmaceutical Pricing and Reimbursement
  • Industry Issues

France

  • Pharmaceutical in France
  • French Pharmaceutical and Healthcare Industry SWOT Analysis
  • Pharmaceutical Pricing and Reimbursement
  • Industry Issues

Germany

  • Pharmaceutical in Germany
  • German Pharmaceutical and Healthcare Industry SWOT Analysis
  • Pharmaceutical Pricing and Reimbursement
  • Industry Issues

Greece

  • Pharmaceutical in Greece
  • Greece Pharmaceutical and Healthcare Industry SWOT Analysis
  • Pharmaceutical Pricing and Reimbursement
  • Industry Issues

Hungary

  • Pharmaceutical in Hungary
  • Hungarian Pharmaceutical and Healthcare Industry SWOT Analysis
  • Pharmaceutical Pricing and Reimbursement
  • Industry Issues

Ireland

  • Pharmaceutical in Ireland
  • Irish Pharmaceutical and Healthcare Industry SWOT Analysis
  • Pharmaceutical Pricing and Reimbursement
  • Industry Issues

Italy

  • Pharmaceutical in Italy
  • Italian Pharmaceutical and Healthcare Industry SWOT Analysis
  • Pharmaceutical Pricing and Reimbursement
  • Industry Issues

Latvia

  • Pharmaceutical in Latvia
  • Latvia Pharmaceutical and Healthcare Industry SWOT Analysis
  • Pharmaceutical Pricing and Reimbursement
  • Industry Issues

Lithuania

  • Pharmaceutical in Lithuania
  • Lithuanian Pharmaceutical and Healthcare Industry SWOT Analysis
  • Pharmaceutical Pricing and Reimbursement
  • Industry Issues

Poland

  • Pharmaceutical in Poland
  • Polish Pharmaceutical and Healthcare Industry SWOT Analysis
  • Pharmaceutical Pricing and Reimbursement
  • Industry Issues

Portugal

  • Pharmaceutical in Portugal
  • Portugal Pharmaceutical and Healthcare Industry SWOT Analysis
  • Pharmaceutical Pricing and Reimbursement
  • Industry Issues

Slovakia

  • Pharmaceutical in Slovakia
  • Slovakian Pharmaceutical and Healthcare Industry SWOT Analysis
  • Pharmaceutical Pricing and Reimbursement
  • Industry Issues

Slovenia

  • Pharmaceutical in Slovenia
  • Slovenian Pharmaceutical and Healthcare Industry SWOT Analysis
  • Pharmaceutical Pricing and Reimbursement
  • Industry Issues

Spain

  • Pharmaceutical in Spain
  • Spanish Pharmaceutical and Healthcare Industry SWOT Analysis
  • Pharmaceutical Pricing and Reimbursement
  • Industry Issues

Sweden

  • Pharmaceutical in Sweden
  • Swedish Pharmaceutical and Healthcare Industry SWOT Analysis
  • Pharmaceutical Pricing and Reimbursement
  • Industry Issues

Switzerland

  • Pharmaceutical in Switzerland
  • Switzerland Pharmaceutical and Healthcare Industry SWOT Analysis
  • Pharmaceutical Pricing and Reimbursement
  • Industry Issues

The Netherlands

  • Pharmaceutical in the Netherlands
  • The Netherlands Pharmaceutical and Healthcare Industry SWOT Analysis
  • Pharmaceutical Pricing and Reimbursement
  • Industry Issues

The United Kingdom

  • Pharmaceutical in the United Kingdom
  • The United Kingdom Pharmaceutical and Healthcare Industry SWOT Analysis
  • Pharmaceutical Pricing and Reimbursement
  • Industry Issues

Pricing and Reimbursement Strategies

  • Pricing and Reimbursement
  • Early Drug Development Phase– A “Foundation Level” Pharmaceutical Pricing and Reimbursement Strategies
  • Mid and Late Drug Development Phase – Pharmaceutical Pricing and Reimbursement Strategies
  • The Decision Phase and Market Entry
  • The Post Launch Phase
Pricing and reimbursement issues for pharmaceutical products in europe
More Information
No Index Yes
Podcast No
Industries Healthcare
WIP Number B705-01-00-00-00
Is Prebook No